Walleye Trading LLC Bristol Myers Squibb CO Call Options Transaction History

Walleye Trading LLC

$41.2 Billion
Q2 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $1.53 Million - $2.01 Million	38,000 Added 16.23%	272,100 $11.3 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $4.43 Million - $5.03 Million	-92,400 Reduced 28.3%	234,100 $12.7 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $2.02 Million - $2.41 Million	41,600 Added 14.6%	326,500 $16.8 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $4.21 Million - $4.71 Million	-72,800 Reduced 20.35%	284,900 $16.5 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $5.2 Million - $5.77 Million	81,600 Added 29.55%	357,700 $22.9 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $374,546 - $424,821	5,700 Added 2.11%	276,100 $19.1 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $4.24 Million - $5.02 Million	-61,900 Reduced 18.63%	270,400 $19.5 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $1,963 - $1.16 Million	-15,100 Reduced 4.35%	332,300 $23.6 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $6.86 Million - $7.55 Million	-94,400 Reduced 21.37%	347,400 $26.8 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $16.5 Million - $19.8 Million	268,200 Added 154.49%	441,800 $32.3 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $2.09 Million - $2.43 Million	-38,900 Reduced 18.31%	173,600 $10.8 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $153,842 - $180,206	2,600 Added 1.24%	212,500 $12.6 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $9.96 Million - $10.8 Million	160,800 Added 327.49%	209,900 $14 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $8.34 Million - $9.38 Million	-140,500 Reduced 74.1%	49,100 $3.1 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $21.2 Million - $24 Million	-366,900 Reduced 65.93%	189,600 $11.8 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $13.4 Million - $14.8 Million	232,500 Added 71.76%	556,500 $33.6 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $416,632 - $487,084	-7,600 Reduced 2.29%	324,000 $19.1 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $2.53 Million - $3.67 Million	-54,500 Reduced 14.12%	331,600 $18.5 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $821,807 - $1.07 Million	-16,700 Reduced 4.15%	386,100 $24.8 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $427,700 - $507,100	-10,000 Reduced 2.42%	402,800 $20.4 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $103 Million - $114 Million	-2,300,500 Reduced 84.79%	412,800 $18.7 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $118 Million - $140 Million	2,605,600 Added 2419.31%	2,713,300 $129 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $1.68 Million - $2.18 Million	-34,500 Reduced 24.26%	107,700 $5.6 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $4.55 Million - $5.13 Million	82,400 Added 137.79%	142,200 $8.83 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $1.77 Million - $2.21 Million	35,100 Added 142.11%	59,800 $3.31 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $2.38 Million - $2.74 Million	-39,700 Reduced 61.65%	24,700 $1.56 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $1.14 Million - $1.24 Million	-19,000 Reduced 22.78%	64,400 $3.95 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $2.99 Million - $3.45 Million	-54,200 Reduced 39.39%	83,400 $5.32 Million
Q2 2017 Aug 14, 2017	BUY	N/A	137,600	137,600 $7.67 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account